Mirae Asset Global Investments Co., Ltd. Vertex Pharmaceuticals Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $28 Billion
  • Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 144,588 shares of VRTX stock, worth $61.5 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
144,588
Previous 143,318 0.89%
Holding current value
$61.5 Million
Previous $69.5 Million 7.36%
% of portfolio
0.23%
Previous 0.19%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025
BUY
$421.16 - $509.5 $534,873 - $647,065
1,270 Added 0.89%
144,588 $64.4 Million
Q1 2025

Apr 24, 2025
BUY
$402.49 - $513.76 $9.57 Million - $12.2 Million
23,769 Added 19.88%
143,318 $69.5 Million
Q4 2024

Jan 27, 2025
BUY
$396.64 - $516.74 $6.85 Million - $8.92 Million
17,264 Added 16.88%
119,549 $48.1 Million
Q3 2024

Oct 23, 2024
BUY
$460.0 - $505.78 $4.61 Million - $5.07 Million
10,016 Added 10.86%
102,285 $47.6 Million
Q2 2024

Jul 30, 2024
SELL
$392.81 - $485.53 $81.9 Million - $101 Million
-208,587 Reduced 69.33%
92,269 $43.2 Million
Q1 2024

May 01, 2024
BUY
$407.69 - $446.08 $1.7 Million - $1.86 Million
4,178 Added 1.41%
300,856 $126 Million
Q4 2023

Jan 24, 2024
SELL
$343.0 - $410.68 $7.52 Million - $9 Million
-21,922 Reduced 6.88%
296,678 $121 Million
Q3 2023

Oct 26, 2023
BUY
$338.18 - $362.46 $13.9 Million - $14.9 Million
41,032 Added 14.78%
318,600 $111 Million
Q2 2023

Aug 10, 2023
SELL
$314.42 - $351.91 $2.31 Million - $2.58 Million
-7,331 Reduced 2.57%
277,568 $97.7 Million
Q1 2023

May 04, 2023
SELL
$283.23 - $323.1 $5.93 Million - $6.76 Million
-20,923 Reduced 6.84%
284,899 $89.8 Million
Q4 2022

Feb 09, 2023
SELL
$285.76 - $321.48 $4.04 Million - $4.55 Million
-14,145 Reduced 4.42%
305,822 $88.3 Million
Q3 2022

Nov 10, 2022
SELL
$273.83 - $305.53 $4.31 Million - $4.81 Million
-15,755 Reduced 4.69%
319,967 $92.7 Million
Q2 2022

Jul 26, 2022
BUY
$234.96 - $292.55 $2.64 Million - $3.28 Million
11,222 Added 3.46%
335,722 $94.6 Million
Q1 2022

May 10, 2022
BUY
$221.42 - $260.97 $8.7 Million - $10.3 Million
39,313 Added 13.78%
324,500 $84.7 Million
Q4 2021

Feb 08, 2022
BUY
$177.01 - $223.45 $6.61 Million - $8.35 Million
37,357 Added 15.07%
285,187 $62.7 Million
Q3 2021

Nov 15, 2021
BUY
$181.39 - $202.99 $14.2 Million - $15.9 Million
78,091 Added 46.01%
247,830 $45 Million
Q2 2021

Aug 11, 2021
SELL
$187.49 - $221.1 $30.3 Million - $35.7 Million
-161,348 Reduced 48.73%
169,739 $34.2 Million
Q1 2021

May 13, 2021
SELL
$207.02 - $241.31 $37.1 Million - $43.3 Million
-179,437 Reduced 35.15%
331,087 $71.1 Million
Q4 2020

Feb 10, 2021
BUY
$207.01 - $276.09 $64.6 Million - $86.2 Million
312,239 Added 157.47%
510,524 $121 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $5.91 Million - $7 Million
23,102 Added 13.19%
198,285 $53.5 Million
Q2 2020

Aug 11, 2020
SELL
$225.48 - $295.8 $20.1 Million - $26.3 Million
-89,068 Reduced 33.71%
175,183 $50.9 Million
Q1 2020

May 12, 2020
BUY
$199.77 - $247.81 $35.4 Million - $43.9 Million
177,194 Added 203.54%
264,251 $62.9 Million
Q4 2019

Feb 12, 2020
BUY
$166.71 - $223.91 $3.71 Million - $4.98 Million
22,228 Added 34.29%
87,057 $19.1 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $1.3 Million - $1.46 Million
7,812 Added 13.7%
64,829 $11 Million
Q2 2019

Aug 13, 2019
BUY
$164.61 - $190.37 $50,864 - $58,824
309 Added 0.54%
57,017 $10.4 Million
Q1 2019

May 13, 2019
BUY
$163.73 - $194.7 $459,262 - $546,133
2,805 Added 5.2%
56,708 $10.4 Million
Q4 2018

Feb 11, 2019
BUY
$151.91 - $192.21 $942,297 - $1.19 Million
6,203 Added 13.0%
53,903 $8.93 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $2.14 Million - $2.46 Million
12,772 Added 36.57%
47,700 $9.15 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $390,238 - $455,152
2,678 Added 8.3%
34,928 $5.61 Million
Q1 2018

May 10, 2018
BUY
$151.6 - $177.13 $448,736 - $524,304
2,960 Added 10.11%
32,250 $5.26 Million
Q4 2017

Feb 12, 2018
SELL
$137.28 - $155.55 $208,391 - $236,124
-1,518 Reduced 4.93%
29,290 $4.39 Million
Q3 2017

Nov 08, 2017
BUY
$148.13 - $162.24 $1.49 Million - $1.63 Million
10,071 Added 48.57%
30,808 $4.66 Million
Q2 2017

Aug 14, 2017
BUY
N/A
20,737
20,737 $2.66 Million

Others Institutions Holding VRTX

# of Institutions
1,784
Shares Held
236M
Call Options Held
1.95M
Put Options Held
1.14M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $109B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email